A comparative clinical evaluation of Virechana Karma with Kashmaryadi Kashaya and Eranda Taila in Vatarakta(Gouty Arthritis)
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 40
- 试验地点
- 1
- 主要终点
- 3. Svathu (Swelling)
研究概览
简要总结
This study is a Comparative Clinical evaluation of Virechana Karma with Kashmaryadi Kasahaya and Eranda Taila in Vatarakata (Gouty Arthritis)
This will be conducted on 40 randomly selected patients from Opd/Ipd of Panchakarma department of Patanjali Bhartiya Ayurvigyan evum Anusandhan Sansthan Haridwar. patient will be divided into 2 groups - 20 patients will be administered Kashmaryadi Kashaya for Virechana and 20 patients will be administered with Eranda Taila for Virechana. Follow up will be taken after 1 month assessment to be done on the basis of subjective and objective parameters as discussed earlier.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 盲法
- None
入排标准
- 年龄范围
- 18.00 Year(s) 至 60.00 Year(s)(—)
- 性别
- All
入选标准
- •Patient present with clinical features of Vatarakta.
- •1.Patient of either sex between age group of 18 to 60 years.
- •2.Patients were selected irrespective of sex, occupation, socio economic status, religion etc.
- •Patient fit for Virechana Karma.
- •Patient showing uric acid level above 7mg/dl.
排除标准
- •Patients below the age of 18 years and above 60 years were excluded.
- •Patient with metabolic disorder, hypertension, systemic disorders, autoimmune diseases, any endocrine disorder and any other malignancy.
- •Patient with infection and communicable disease.
- •Patients who are pregnant and lactating mother.
- •Patient associated with Rheumatoid arthritis, osteoarthritis.
- •Patient with anorectal diseases like fistula and hemorrhoids.
结局指标
主要结局
3. Svathu (Swelling)
时间窗: 10,30 days
1. Arti (Pain)
时间窗: 10,30 days
2. Stabhdhata (Stiffness)
时间窗: 10,30 days
4. Daha (Burning)
时间窗: 10,30 days
5. Vaivarnya (Discoloration)
时间窗: 10,30 days
次要结局
- Objective parameter(1. CBC with ESR)
研究者
Akansha Singh
Patanjali Bhartiya Ayurvigyan Evum Anusandhan Sansthan Haridwar Uttarakhand
